- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Indoco Remedies' board approved Q3 FY26 consolidated results. The company reported a net loss of ₹29.45 Cr on revenues of ₹434.34 Cr. Exceptional items impacted the quarter.